Prices delayed by at least 15 minutes | Prices updated on 23 May 2025, 18.22 BST | Print
Oxford Biomedica PLC (OXB)
ORD 50PThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment
Company profile
Oxford BioMedica PLC is a contract development and manufacturing organization (CDMO) focused on cell and gene therapy. The company specializes in viral vector development and manufacturing for cell and gene therapy, with expertise in lentivirus, adeno-associated virus (AAV), adenovirus, and other viral vector types.
Address
Windrush Court
Transport Way
Oxford
GBR
OX4 6LT
Telephone
+44 1865783000
Major shareholders
| Name | Amount | Holding (%) |
|---|---|---|
| Briarwood Chase Management LLC | 12,739,828 | 12.02 |
| Novo Holdings | 12,048,802 | 11.37 |
| Institut Merieux SA | 11,510,481 | 10.86 |
| Novo Nordisk Foundation | 7,750,000 | 10.10 |
| Vulpes Life Science Fund | 8,447,390 | 7.97 |
| M&G Investment Management Limited | 5,872,847 | 5.54 |
| Columbia Threadneedle Investments | 3,834,977 | 3.62 |
| Hargreaves Lansdown Asset Mgmt Ltd | 3,475,237 | 3.28 |
| Serum Institute of India Ltd | 3,382,950 | 3.19 |
Key personnel
| Name | Position |
|---|---|
| Mr. John Andrew Dawson CBE | Executive Director,Chief Executive Officer |
| Dr. Roch F. Doliveux | Non-Executive Director,Chairman |
| Dr. Frank Mathias | Executive Director,Chief Executive Officer |
| Dr. Heather Elizabeth Preston, M.D. | Non-Executive Director |
| Mr. Stuart Henderson | Non-Executive Director,Vice Chairman |
| Professor Dame Kay Davies | Non-Executive Director,Senior Independent Director |
| Ms. Namrata P Patel | Non-Executive Director |
| Ms. Lucinda Crabtree | Executive Director,Chief Financial Officer |
Forecast key dates
Previous key dates
Activity analysis
Geographical analysis
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.